Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Silverback Therapeutics Inc (SBTX)

Silverback Therapeutics Inc (SBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Silverback Therapeutics Inc 500 Fairview Ave N Suite 600 Seattle WA 98109 USA

www.silverbacktx.com P: 206-456-2900

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Silverback Therapeutics Inc. is a clinical-stage biopharmaceutical company. Its ImmunoTAC technology platform, develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections and other serious diseases. Silverback Therapeutics Inc. is based in Seattle, United States.

Key Statistics

Overview:

Market Capitalization, $K 211,660
Enterprise Value, $K -42,390
Shares Outstanding, K 36,058
Float, K 23,654
% Float 65.60%
Short Volume Ratio 0.35
% of Insider Shareholders 34.40%
% of Institutional Shareholders 74.89%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -89,480 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -17,860 K

Growth:

1-Year Return -33.30%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.50 on 11/02/22
Next Earnings Date 03/30/23
Earnings Per Share ttm -2.42
EPS Growth vs. Prev Qtr 9.09%
EPS Growth vs. Prev Year 23.08%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SBTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.62%
Return-on-Assets % -28.20%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.78
Book Value/Share 7.53
Interest Coverage 0.00
60-Month Beta 0.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.